Has Divyajot Sandhu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $307,547 in general payments to Divyajot Sandhu, MD across 172 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Divyajot Sandhu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Divyajot Sandhu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Divyajot Sandhu, MD

Vascular Neurology · Sioux Falls, SDNPI 1790915973

Payments from drug & device makers

$307,547in general payments, 2019–2025

Across 172 payments — averaging $1788.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Microvention, Inc.$305K
Stryker$1K
Johnson & Johnson$850
Imperative Care, Inc$357
Route 92 Medical, Inc.$192
Microtransponder, Inc.$164
plus $420 from 6 others

What the payments were for

Consulting fees$1,50011%
Travel & lodging$6,18044%
Food & beverage$6,37245%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Microvention, Inc.	128	$304,561
Stryker	7	$1,002
Johnson & Johnson	14	$850
Imperative Care, Inc	7	$357
Route 92 Medical, Inc.	4	$192
Microtransponder, Inc.	1	$164
Penumbra, Inc.	2	$157
Medtronic	3	$122
Terumo Medical Corporation	3	$83
Genentech USA, Inc.	1	$25
Amgen	1	$17
Boston Scientific	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular neurology providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$119,810

Medicare patients

222

Services billed

725

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BrilintaTicagrelor	13	$4,187
ClopidogrelClopidogrel Bisulfate	29	$171
Oxcarbazepine	13	$147
Atorvastatin Calcium	12	$37

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Sioux Falls

Alex LinnSioux Falls$3K
Ryan GianatasioRapid City$3K
Erica StoddardRapid City$2K

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →